世界のペプチド治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Peptide Therapeutics Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4502 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、ペプチド治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、経口、その他）、用途別市場規模（がん、代謝障害、中枢神経系、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ペプチド治療薬の市場動向 ・企業の競争状況、市場シェア ・ペプチド治療薬の種類別市場規模（注射、経口、その他） ・ペプチド治療薬の用途別市場規模（がん、代謝障害、中枢神経系、その他） ・ペプチド治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・ペプチド治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ペプチド治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ペプチド治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・ペプチド治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sanofi、Eli Lilly、Novo Nordisk、Takeda、Teva、Novartis、AstraZeneca、Ipsen、AbbVie、Allergan、Ferring、Merck、JNJ、Tarix Pharmaceuticals、Lonza） ・結論

Market Analysis and Insights: Global Peptide Therapeutics Drugs Market
The global Peptide Therapeutics Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peptide Therapeutics Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Peptide Therapeutics Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Peptide Therapeutics Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Peptide Therapeutics Drugs market.

Global Peptide Therapeutics Drugs Scope and Market Size
Peptide Therapeutics Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Peptide Therapeutics Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Injection
Oral
Other

Segment by Application
Cancer
Metabolic Disorders
Central Nervous System
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi
Eli Lilly
Novo Nordisk
Takeda
Teva
Novartis
AstraZeneca
Ipsen
AbbVie
Allergan
Ferring
Merck
JNJ

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Therapeutics Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injection
1.2.3 Oral
1.2.4 Other
1.3 Market by Application
1.3.1 Global Peptide Therapeutics Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Peptide Therapeutics Drugs Market Perspective (2016-2027)
2.2 Peptide Therapeutics Drugs Growth Trends by Regions
2.2.1 Peptide Therapeutics Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Peptide Therapeutics Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Peptide Therapeutics Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Peptide Therapeutics Drugs Industry Dynamic
2.3.1 Peptide Therapeutics Drugs Market Trends
2.3.2 Peptide Therapeutics Drugs Market Drivers
2.3.3 Peptide Therapeutics Drugs Market Challenges
2.3.4 Peptide Therapeutics Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Peptide Therapeutics Drugs Players by Revenue
3.1.1 Global Top Peptide Therapeutics Drugs Players by Revenue (2016-2021)
3.1.2 Global Peptide Therapeutics Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Peptide Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Peptide Therapeutics Drugs Revenue
3.4 Global Peptide Therapeutics Drugs Market Concentration Ratio
3.4.1 Global Peptide Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Therapeutics Drugs Revenue in 2020
3.5 Peptide Therapeutics Drugs Key Players Head office and Area Served
3.6 Key Players Peptide Therapeutics Drugs Product Solution and Service
3.7 Date of Enter into Peptide Therapeutics Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide Therapeutics Drugs Breakdown Data by Type
4.1 Global Peptide Therapeutics Drugs Historic Market Size by Type (2016-2021)
4.2 Global Peptide Therapeutics Drugs Forecasted Market Size by Type (2022-2027)

5 Peptide Therapeutics Drugs Breakdown Data by Application
5.1 Global Peptide Therapeutics Drugs Historic Market Size by Application (2016-2021)
5.2 Global Peptide Therapeutics Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Peptide Therapeutics Drugs Market Size (2016-2027)
6.2 North America Peptide Therapeutics Drugs Market Size by Type
6.2.1 North America Peptide Therapeutics Drugs Market Size by Type (2016-2021)
6.2.2 North America Peptide Therapeutics Drugs Market Size by Type (2022-2027)
6.2.3 North America Peptide Therapeutics Drugs Market Size by Type (2016-2027)
6.3 North America Peptide Therapeutics Drugs Market Size by Application
6.3.1 North America Peptide Therapeutics Drugs Market Size by Application (2016-2021)
6.3.2 North America Peptide Therapeutics Drugs Market Size by Application (2022-2027)
6.3.3 North America Peptide Therapeutics Drugs Market Size by Application (2016-2027)
6.4 North America Peptide Therapeutics Drugs Market Size by Country
6.4.1 North America Peptide Therapeutics Drugs Market Size by Country (2016-2021)
6.4.2 North America Peptide Therapeutics Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Peptide Therapeutics Drugs Market Size (2016-2027)
7.2 Europe Peptide Therapeutics Drugs Market Size by Type
7.2.1 Europe Peptide Therapeutics Drugs Market Size by Type (2016-2021)
7.2.2 Europe Peptide Therapeutics Drugs Market Size by Type (2022-2027)
7.2.3 Europe Peptide Therapeutics Drugs Market Size by Type (2016-2027)
7.3 Europe Peptide Therapeutics Drugs Market Size by Application
7.3.1 Europe Peptide Therapeutics Drugs Market Size by Application (2016-2021)
7.3.2 Europe Peptide Therapeutics Drugs Market Size by Application (2022-2027)
7.3.3 Europe Peptide Therapeutics Drugs Market Size by Application (2016-2027)
7.4 Europe Peptide Therapeutics Drugs Market Size by Country
7.4.1 Europe Peptide Therapeutics Drugs Market Size by Country (2016-2021)
7.4.2 Europe Peptide Therapeutics Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Peptide Therapeutics Drugs Market Size (2016-2027)
8.2 Asia-Pacific Peptide Therapeutics Drugs Market Size by Type
8.2.1 Asia-Pacific Peptide Therapeutics Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Peptide Therapeutics Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Peptide Therapeutics Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Peptide Therapeutics Drugs Market Size by Application
8.3.1 Asia-Pacific Peptide Therapeutics Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Peptide Therapeutics Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Peptide Therapeutics Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Peptide Therapeutics Drugs Market Size by Region
8.4.1 Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Peptide Therapeutics Drugs Market Size (2016-2027)
9.2 Latin America Peptide Therapeutics Drugs Market Size by Type
9.2.1 Latin America Peptide Therapeutics Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Peptide Therapeutics Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Peptide Therapeutics Drugs Market Size by Type (2016-2027)
9.3 Latin America Peptide Therapeutics Drugs Market Size by Application
9.3.1 Latin America Peptide Therapeutics Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Peptide Therapeutics Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Peptide Therapeutics Drugs Market Size by Application (2016-2027)
9.4 Latin America Peptide Therapeutics Drugs Market Size by Country
9.4.1 Latin America Peptide Therapeutics Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Peptide Therapeutics Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Peptide Therapeutics Drugs Market Size (2016-2027)
10.2 Middle East & Africa Peptide Therapeutics Drugs Market Size by Type
10.2.1 Middle East & Africa Peptide Therapeutics Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Peptide Therapeutics Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Peptide Therapeutics Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Peptide Therapeutics Drugs Market Size by Application
10.3.1 Middle East & Africa Peptide Therapeutics Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Peptide Therapeutics Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Peptide Therapeutics Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Peptide Therapeutics Drugs Market Size by Country
10.4.1 Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Peptide Therapeutics Drugs Introduction
11.1.4 Sanofi Revenue in Peptide Therapeutics Drugs Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Peptide Therapeutics Drugs Introduction
11.2.4 Eli Lilly Revenue in Peptide Therapeutics Drugs Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Peptide Therapeutics Drugs Introduction
11.3.4 Novo Nordisk Revenue in Peptide Therapeutics Drugs Business (2016-2021)
11.3.5 Novo Nordisk Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Peptide Therapeutics Drugs Introduction
11.4.4 Takeda Revenue in Peptide Therapeutics Drugs Business (2016-2021)
11.4.5 Takeda Recent Development
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Peptide Therapeutics Drugs Introduction
11.5.4 Teva Revenue in Peptide Therapeutics Drugs Business (2016-2021)
11.5.5 Teva Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Peptide Therapeutics Drugs Introduction
11.6.4 Novartis Revenue in Peptide Therapeutics Drugs Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Peptide Therapeutics Drugs Introduction
11.7.4 AstraZeneca Revenue in Peptide Therapeutics Drugs Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Ipsen
11.8.1 Ipsen Company Details
11.8.2 Ipsen Business Overview
11.8.3 Ipsen Peptide Therapeutics Drugs Introduction
11.8.4 Ipsen Revenue in Peptide Therapeutics Drugs Business (2016-2021)
11.8.5 Ipsen Recent Development
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 AbbVie Business Overview
11.9.3 AbbVie Peptide Therapeutics Drugs Introduction
11.9.4 AbbVie Revenue in Peptide Therapeutics Drugs Business (2016-2021)
11.9.5 AbbVie Recent Development
11.10 Allergan
11.10.1 Allergan Company Details
11.10.2 Allergan Business Overview
11.10.3 Allergan Peptide Therapeutics Drugs Introduction
11.10.4 Allergan Revenue in Peptide Therapeutics Drugs Business (2016-2021)
11.10.5 Allergan Recent Development
11.11 Ferring
11.11.1 Ferring Company Details
11.11.2 Ferring Business Overview
11.11.3 Ferring Peptide Therapeutics Drugs Introduction
11.11.4 Ferring Revenue in Peptide Therapeutics Drugs Business (2016-2021)
11.11.5 Ferring Recent Development
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Peptide Therapeutics Drugs Introduction
11.12.4 Merck Revenue in Peptide Therapeutics Drugs Business (2016-2021)
11.12.5 Merck Recent Development
11.13 JNJ
11.13.1 JNJ Company Details
11.13.2 JNJ Business Overview
11.13.3 JNJ Peptide Therapeutics Drugs Introduction
11.13.4 JNJ Revenue in Peptide Therapeutics Drugs Business (2016-2021)
11.13.5 JNJ Recent Development
11.14 Tarix Pharmaceuticals
11.14.1 Tarix Pharmaceuticals Company Details
11.14.2 Tarix Pharmaceuticals Business Overview
11.14.3 Tarix Pharmaceuticals Peptide Therapeutics Drugs Introduction
11.14.4 Tarix Pharmaceuticals Revenue in Peptide Therapeutics Drugs Business (2016-2021)
11.14.5 Tarix Pharmaceuticals Recent Development
11.15 Lonza
11.15.1 Lonza Company Details
11.15.2 Lonza Business Overview
11.15.3 Lonza Peptide Therapeutics Drugs Introduction
11.15.4 Lonza Revenue in Peptide Therapeutics Drugs Business (2016-2021)
11.15.5 Lonza Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Peptide Therapeutics Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Injection
Table 3. Key Players of Oral
Table 4. Key Players of Other
Table 5. Global Peptide Therapeutics Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Peptide Therapeutics Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Peptide Therapeutics Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Peptide Therapeutics Drugs Market Share by Regions (2016-2021)
Table 9. Global Peptide Therapeutics Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Peptide Therapeutics Drugs Market Share by Regions (2022-2027)
Table 11. Peptide Therapeutics Drugs Market Trends
Table 12. Peptide Therapeutics Drugs Market Drivers
Table 13. Peptide Therapeutics Drugs Market Challenges
Table 14. Peptide Therapeutics Drugs Market Restraints
Table 15. Global Peptide Therapeutics Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Peptide Therapeutics Drugs Market Share by Players (2016-2021)
Table 17. Global Top Peptide Therapeutics Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Therapeutics Drugs as of 2020)
Table 18. Ranking of Global Top Peptide Therapeutics Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Peptide Therapeutics Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Peptide Therapeutics Drugs Product Solution and Service
Table 22. Date of Enter into Peptide Therapeutics Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Peptide Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Peptide Therapeutics Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Peptide Therapeutics Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Peptide Therapeutics Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Peptide Therapeutics Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Peptide Therapeutics Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Peptide Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Peptide Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Peptide Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Peptide Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Peptide Therapeutics Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Peptide Therapeutics Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Peptide Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Peptide Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Peptide Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Peptide Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Peptide Therapeutics Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Peptide Therapeutics Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Peptide Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Peptide Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Peptide Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Peptide Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Peptide Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Peptide Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Peptide Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Peptide Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Peptide Therapeutics Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Peptide Therapeutics Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Peptide Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Peptide Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Peptide Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Peptide Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Sanofi Company Details
Table 63. Sanofi Business Overview
Table 64. Sanofi Peptide Therapeutics Drugs Product
Table 65. Sanofi Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 66. Sanofi Recent Development
Table 67. Eli Lilly Company Details
Table 68. Eli Lilly Business Overview
Table 69. Eli Lilly Peptide Therapeutics Drugs Product
Table 70. Eli Lilly Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 71. Eli Lilly Recent Development
Table 72. Novo Nordisk Company Details
Table 73. Novo Nordisk Business Overview
Table 74. Novo Nordisk Peptide Therapeutics Drugs Product
Table 75. Novo Nordisk Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 76. Novo Nordisk Recent Development
Table 77. Takeda Company Details
Table 78. Takeda Business Overview
Table 79. Takeda Peptide Therapeutics Drugs Product
Table 80. Takeda Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 81. Takeda Recent Development
Table 82. Teva Company Details
Table 83. Teva Business Overview
Table 84. Teva Peptide Therapeutics Drugs Product
Table 85. Teva Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 86. Teva Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Peptide Therapeutics Drugs Product
Table 90. Novartis Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. AstraZeneca Company Details
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Peptide Therapeutics Drugs Product
Table 95. AstraZeneca Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 96. AstraZeneca Recent Development
Table 97. Ipsen Company Details
Table 98. Ipsen Business Overview
Table 99. Ipsen Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 100. Ipsen Recent Development
Table 101. AbbVie Company Details
Table 102. AbbVie Business Overview
Table 103. AbbVie Peptide Therapeutics Drugs Product
Table 104. AbbVie Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 105. AbbVie Recent Development
Table 106. Allergan Company Details
Table 107. Allergan Business Overview
Table 108. Allergan Peptide Therapeutics Drugs Product
Table 109. Allergan Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 110. Allergan Recent Development
Table 111. Ferring Company Details
Table 112. Ferring Business Overview
Table 113. Ferring Peptide Therapeutics Drugs Product
Table 114. Ferring Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 115. Ferring Recent Development
Table 116. Merck Company Details
Table 117. Merck Business Overview
Table 118. Merck Peptide Therapeutics Drugs Product
Table 119. Merck Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 120. Merck Recent Development
Table 121. JNJ Company Details
Table 122. JNJ Business Overview
Table 123. JNJ Peptide Therapeutics Drugs Product
Table 124. JNJ Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 125. JNJ Recent Development
Table 126. Tarix Pharmaceuticals Company Details
Table 127. Tarix Pharmaceuticals Business Overview
Table 128. Tarix Pharmaceuticals Peptide Therapeutics Drugs Product
Table 129. Tarix Pharmaceuticals Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 130. Tarix Pharmaceuticals Recent Development
Table 131. Lonza Company Details
Table 132. Lonza Business Overview
Table 133. Lonza Peptide Therapeutics Drugs Product
Table 134. Lonza Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million)
Table 135. Lonza Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide Therapeutics Drugs Market Share by Type: 2020 VS 2027
Figure 2. Injection Features
Figure 3. Oral Features
Figure 4. Other Features
Figure 5. Global Peptide Therapeutics Drugs Market Share by Application: 2020 VS 2027
Figure 6. Cancer Case Studies
Figure 7. Metabolic Disorders Case Studies
Figure 8. Central Nervous System Case Studies
Figure 9. Other Case Studies
Figure 10. Peptide Therapeutics Drugs Report Years Considered
Figure 11. Global Peptide Therapeutics Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Peptide Therapeutics Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Peptide Therapeutics Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Peptide Therapeutics Drugs Market Share by Regions (2022-2027)
Figure 15. Global Peptide Therapeutics Drugs Market Share by Players in 2020
Figure 16. Global Top Peptide Therapeutics Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Therapeutics Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Peptide Therapeutics Drugs Revenue in 2020
Figure 18. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Peptide Therapeutics Drugs Market Share by Type (2016-2027)
Figure 22. North America Peptide Therapeutics Drugs Market Share by Application (2016-2027)
Figure 23. North America Peptide Therapeutics Drugs Market Share by Country (2016-2027)
Figure 24. United States Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Peptide Therapeutics Drugs Market Share by Type (2016-2027)
Figure 28. Europe Peptide Therapeutics Drugs Market Share by Application (2016-2027)
Figure 29. Europe Peptide Therapeutics Drugs Market Share by Country (2016-2027)
Figure 30. Germany Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Peptide Therapeutics Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Peptide Therapeutics Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Peptide Therapeutics Drugs Market Share by Region (2016-2027)
Figure 40. China Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Peptide Therapeutics Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Peptide Therapeutics Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Peptide Therapeutics Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Peptide Therapeutics Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Peptide Therapeutics Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Peptide Therapeutics Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Sanofi Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
Figure 60. Eli Lilly Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
Figure 61. Novo Nordisk Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
Figure 62. Takeda Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
Figure 63. Teva Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
Figure 66. Ipsen Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
Figure 67. AbbVie Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
Figure 68. Allergan Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
Figure 69. Ferring Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
Figure 70. Merck Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
Figure 71. JNJ Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
Figure 72. Tarix Pharmaceuticals Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
Figure 73. Lonza Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

---